200 related articles for article (PubMed ID: 19765220)
21. Interleukin-10 production after pro-inflammatory stimulation of neutrophils and monocytic cells of the newborn. Comparison to exogenous interleukin-10 and dexamethasone levels needed to inhibit chemokine release.
Davidson D; Miskolci V; Clark DC; Dolmaian G; Vancurova I
Neonatology; 2007; 92(2):127-33. PubMed ID: 17389814
[TBL] [Abstract][Full Text] [Related]
22. mRNA expression patterns of the BPI/LBP molecule in the Atlantic cod (Gadus morhua L.).
Solstad T; Stenvik J; Jørgensen TØ
Fish Shellfish Immunol; 2007 Aug; 23(2):260-71. PubMed ID: 17442589
[TBL] [Abstract][Full Text] [Related]
23. [Changes in Toll-like receptor 2 and 4 gene expression in vital organs in septic rats and their regulation mechanisms].
Yao YM; Yan XJ; Yao FH; Cheng MH; Dong N; Yu Y; Sheng ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Nov; 15(11):646-50. PubMed ID: 14604479
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
25. Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages.
Amura CR; Chen LC; Hirohashi N; Lei MG; Morrison DC
J Immunol; 1997 Nov; 159(10):5079-83. PubMed ID: 9366436
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and characterization of LPS-binding protein/bactericidal permeability-increasing protein (LBP/BPI) from olive flounder, Paralichthys olivaceus.
Nam BH; Ahn KJ; Kim YO; Kong HJ; Kim WJ; Kim HS; Lee SJ; Kim KK
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):256-63. PubMed ID: 19698997
[TBL] [Abstract][Full Text] [Related]
27. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis.
Galbois A; Thabut D; Tazi KA; Rudler M; Mohammadi MS; Bonnefont-Rousselot D; Bennani H; Bezeaud A; Tellier Z; Guichard C; Coant N; Ogier-Denis E; Moreau R; Lebrec D
Hepatology; 2009 Jan; 49(1):175-84. PubMed ID: 19053046
[TBL] [Abstract][Full Text] [Related]
29. In vitro effects of Escherichia coli lipopolysaccharide on the function and gene expression of neutrophils isolated from the blood of dairy cows.
Revelo XS; Waldron MR
J Dairy Sci; 2012 May; 95(5):2422-41. PubMed ID: 22541470
[TBL] [Abstract][Full Text] [Related]
30. Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signalling in cirrhotic patients.
Marotta F; Chui DH; Jain S; Polimeni A; Koike K; Zhou L; Lorenzetti A; Shimizu H; Yang H
J Biol Regul Homeost Agents; 2011; 25(1):37-45. PubMed ID: 21382272
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
[TBL] [Abstract][Full Text] [Related]
32. Extracellular release of bactericidal/permeability-increasing protein in newborn infants.
Nupponen I; Turunen R; Nevalainen T; Peuravuori H; Pohjavuori M; Repo H; Andersson S
Pediatr Res; 2002 Jun; 51(6):670-4. PubMed ID: 12032259
[TBL] [Abstract][Full Text] [Related]
33. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
[TBL] [Abstract][Full Text] [Related]
34. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor-κB mediated lipopolysaccharide-induced mRNA expression of hepcidin in human peripheral blood leukocytes.
Wu S; Zhang K; Lv C; Wang H; Cheng B; Jin Y; Chen Q; Lian Q; Fang X
Innate Immun; 2012 Apr; 18(2):318-24. PubMed ID: 21685415
[TBL] [Abstract][Full Text] [Related]
36. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
37. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
[TBL] [Abstract][Full Text] [Related]
38. The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Wang RH; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Apr; 9(2):197-202. PubMed ID: 22409502
[TBL] [Abstract][Full Text] [Related]
39. Altered inflammatory responses in preterm children with cerebral palsy.
Lin CY; Chang YC; Wang ST; Lee TY; Lin CF; Huang CC
Ann Neurol; 2010 Aug; 68(2):204-12. PubMed ID: 20695013
[TBL] [Abstract][Full Text] [Related]
40. Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length.
Jahr TG; Sundan A; Lichenstein HS; Espevik T
Scand J Immunol; 1995 Jul; 42(1):119-27. PubMed ID: 7543211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
